Benzinga | Jun 17, 2021 09:18AM EDT

Citigroup Initiates Coverage On Haemonetics with Buy Rating, Announces Price Target of $75

Citigroup analyst Joanne Wuensch initiates coverage on Haemonetics (NYSE:HAE) with a Buy rating and announces Price Target of $75.Citigroup analyst Joanne Wuensch initiates coverage on Haemonetics (NYSE:HAE) with a Buy rating and announces Price Target of $75.